| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 3e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |